SHERLOCK: nucleic acid detection with CRISPR nucleases

Rapid detection of nucleic acids is integral to applications in clinical diagnostics and biotechnology. We have recently established a CRISPR-based diagnostic platform that combines nucleic acid pre-amplification with CRISPR–Cas enzymology for specific recognition of desired DNA or RNA sequences. This platform, termed specific high-sensitivity enzymatic reporter unlocking (SHERLOCK), allows multiplexed, portable, and ultra-sensitive detection of RNA or DNA from clinically relevant samples. Here, we provide step-by-step instructions for setting up SHERLOCK assays with recombinase-mediated polymerase pre-amplification of DNA or RNA and subsequent Cas13- or Cas12-mediated detection via fluorescence and colorimetric readouts that provide results in <1 h with a setup time of less than 15 min. We also include guidelines for designing efficient CRISPR RNA (crRNA) and isothermal amplification primers, as well as discuss important considerations for multiplex and quantitative SHERLOCK detection assays. Specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) allows multiplexed, portable, and ultra-sensitive detection of RNA or DNA from clinically relevant samples.

[1]  Adam Ameur,et al.  Single-Molecule Sequencing: Towards Clinical Applications. , 2019, Trends in biotechnology.

[2]  Jin-Soo Kim,et al.  Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells , 2016, Nature Biotechnology.

[3]  Eugene V Koonin,et al.  Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems. , 2015, Molecular cell.

[4]  S. Konermann,et al.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors , 2018, Cell.

[5]  P. Neužil,et al.  Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes , 2006, Nucleic acids research.

[6]  Guozhen Liu,et al.  CRISPR/Cas Systems towards Next-Generation Biosensing. , 2019, Trends in biotechnology.

[7]  L. G. Pacheco,et al.  Detecting pathogens with Zinc-Finger, TALE and CRISPR- based programmable nucleic acid binding proteins. , 2018, Journal of microbiological methods.

[8]  Timon Idema,et al.  CRISPR-based DNA and RNA detection with liquid phase separation , 2018, bioRxiv.

[9]  Hayden C. Metsky,et al.  Field-deployable viral diagnostics using CRISPR-Cas13 , 2018, Science.

[10]  D. Burstein,et al.  RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes. , 2017, Molecular cell.

[11]  Qiu-Xiang Cheng,et al.  CRISPR-Cas12a-assisted nucleic acid detection , 2018, Cell Discovery.

[12]  Martin J. Aryee,et al.  Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells , 2016, Nature Biotechnology.

[13]  D. Richman,et al.  Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Regev,et al.  Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System , 2015, Cell.

[15]  Kira S. Makarova,et al.  Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL domain-containing accessory protein , 2018, Molecular cell.

[16]  Yasuyoshi Mori,et al.  Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products , 2008, Nature Protocols.

[17]  James J. Collins,et al.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 , 2018, Science.

[18]  J. Compton,et al.  Nucleic acid sequence-based amplification , 1991, Nature.

[19]  Eric S. Lander,et al.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016, Science.

[20]  Mandeep Sandhu,et al.  Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor , 2019, Nature Biomedical Engineering.

[21]  Jian Ye,et al.  Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.

[22]  Olaf Piepenburg,et al.  DNA Detection Using Recombination Proteins , 2006, PLoS biology.

[23]  Sergey A. Shmakov,et al.  Cas13b is a Type VI-B CRISPR-associated RNA-Guided RNase differentially regulated by accessory proteins Csx27 and Csx28 , 2016, bioRxiv.

[24]  Jennifer A. Doudna,et al.  CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity , 2018, Science.

[25]  R. Bhattacharyya,et al.  Harnessing CRISPR Effectors for Infectious Disease Diagnostics. , 2018, ACS infectious diseases.

[26]  Shiyuan Li,et al.  CRISPR-Cas12b-assisted nucleic acid detection platform , 2018, bioRxiv.

[27]  Jennifer A. Doudna,et al.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection , 2016, Nature.

[28]  Qiu-Xiang Cheng,et al.  CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA , 2018, Cell Research.

[29]  Carl T Wittwer,et al.  Extreme PCR: efficient and specific DNA amplification in 15-60 seconds. , 2015, Clinical chemistry.

[30]  Yan Xu,et al.  Helicase‐dependent isothermal DNA amplification , 2004, EMBO reports.

[31]  Aviv Regev,et al.  RNA targeting with CRISPR–Cas13 , 2017, Nature.

[32]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[33]  Angelika Niemz,et al.  Point-of-care nucleic acid testing for infectious diseases. , 2011, Trends in biotechnology.